Sector: Pharmaceuticals & Biotechnology

Mid Cap

Corona Remedies Share Price

Corona Remedies Ltd.

₹1,699.90

15.30(0.91%)

Trade Now

25th May 2026 | 11:09 AM

NSE : CORONA

Open Free Demat Account

Corona Remedies Performance

Price Movement

₹1699.90

₹1684.60

₹1719.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1699.90

₹1336.60

₹1949.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,719.90

Low₹1,684.60

Open at₹1,718.00

Prev Close₹1,684.60

Volumes18.85 K

Avg Price₹1,709.97

Lower Circuit₹1,347.70

Upper Circuit₹2,021.50

Historical Performance

3M High₹1,949.40

3M Low₹1,372.30

1 Yr High₹1,949.40

1 Yr Low₹1,336.60

3 Yr High₹1,949.40

3 Yr Low₹1,336.60

5 Yr High₹1,949.40

5 Yr Low₹1,336.60

Corona Remedies Fundamentals

Market Cap

High in industry

10,591.70 Cr.

PE Ratio (TTM)

High in industry

57.20

Dividend Yield

Net Profit TTM

185.12

Net Profit Growth

185.12

PEG Ratio

ROE

0.6% incr over last year

24.78

Operating Revenue TTM

1,403.18

Operating Revenue Growth

Book Value

High in industry

15.10

MFI

MFI is mid-range

48.04

RSI

RSI is mid-range

53.35

EPS (TTM)

30.27

Debt to Equity

0.19

Face Value

Operating Profit Margin Qtr.

20.75

Operating Profit Qtr.

62.02

Net Profit Qtr.

45.33

Operating Revenue Qtr.

353.09

PB Ratio

15.10

Corona Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	353.09	342.42	361.13	346.54	293.69
Operating Expense	291.07	259.26	282.66	276.76	239.47
Operating Profit	62.02	83.16	78.47	69.78	54.22
Depreciation	10.29	9.45	9.20	8.92	10.04
Interest	1.38	1.66	1.93	1.99	2.20
Tax	9.41	13.94	17.46	14.49	12.06
Net Profit	45.05	41.25	52.15	46.40	31.34

Corona Remedies Technicals

Corona Remedies Ltd. EMA & SMA

₹1699.90

-81.90 (-4.60%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1760.3

Day EMA10 ₹1748.3

Day EMA12 ₹1742.2

Day EMA20 ₹1717.6

Day EMA26 ₹1701.3

Day EMA50 ₹1649.1

Day EMA100 ₹1564.8

Corona Remedies Support and Resistance

Resistance

First Resistance₹1800.40

Second Resistance₹1869.00

Third Resistance₹1908.20

Support

First Support₹1692.60

Second Support₹1653.40

Third Support₹1584.80

Technical Indicators

Day RSI53.35

Day MFI48.04

Day ADX23.88

Day Commodity Channel Index55.90

William-62.78

Day MACD40.95

Day MACD Signal Line40.48

Day ATR91.00

Day ROC125-

Day ROC211.97

Corona Remedies Shareholding Pattern

Held By	Dec 2025	Mar 2026
Promoter	69	69
FII	1.8	2.2
DII	6.8	7.1
Public	22.4	21.8

Corona Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	94.92 K	1.18 L	80.12%
Week	47.79 K	84.38 K	56.64%
1 Month	27.31 K	60.9 K	44.84%
6 Month	74.69 K	2.28 L	32.73%

Corona Remedies SWOT Analysis

Strengths19

Weakness9

Opportunity1

Threats2

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Corona Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Jun, 2026	10	FINAL	19 Jun, 2026	Equity Share

Corona Remedies Stock Comparison

Financials	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Senores Pharmaceuticals Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹724.95	₹953.50	₹1,145.70	₹4,689.70	₹519.30
% Change	7.66%	0.39%	3.13%	-0.96%	-0.14%
Revenue TTM (₹ Cr)	-	₹1,598.19	₹649.50	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	-	₹206.20	₹115.38	₹257.90	₹255.19
PE TTM	-	78.90	43.30	43.40	31.80
1 Year Return	9.63	103.31	111.14	-2.21	-6.77
ROCE	34.78	34.76	15.60	-	11.40

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 445.35

+0.97%

CONCORDBIO

Concord Biotech Ltd.

₹ 1156.70

+0.29%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 727.80

+2.06%

SUPRIYA

Supriya Lifescience Ltd.

₹ 783.45

+1.21%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1041.50

+0.24%

COHANCE

Cohance Lifesciences Ltd.

₹ 428.75

+2.44%

ERIS

Eris Lifesciences Ltd.

₹ 1345.10

+0.10%

SYNGENE

Syngene International Ltd.

₹ 465.80

+0.86%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 757.50

+0.24%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 226.41

+7.93%

STAR

Strides Pharma Science Ltd.

₹ 1176.60

+2.03%

GRANULES

Granules India Ltd.

₹ 760.30

+1.11%

FDC

FDC Ltd.

₹ 369.70

-0.95%

SHILPAMED

Shilpa Medicare Ltd.

₹ 510.85

+4.20%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 970.00

-3.61%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2067.00

+1.92%

MARKSANS

Marksans Pharma Ltd.

₹ 218.90

+3.32%

SANOFI

Sanofi India Ltd.

₹ 3159.40

-0.12%

PGHL

Procter & Gamble Health Ltd.

₹ 5601.00

+0.86%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 628.00

-3.35%

FAQ's on CORONA

What is the current share price of Corona Remedies Ltd.?

As of 20 May 2026 at 10:19 AM, the share price for Corona Remedies Ltd. is ₹ 1699.9 on the NSE and ₹ 1697.55 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Corona Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 20 May 2026, the market cap for Corona Remedies Ltd. is approximately ₹ 10591.7 Cr.

What are the PE and PB ratios for Corona Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Corona Remedies Ltd. is 57.2, and the Price-to-Book (PB) ratio is 15.1.

What is the 52-Week High and Low for Corona Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Corona Remedies Ltd. shares was ₹ 1949.4, and the lowest price was ₹ 1336.6.

Who are the major shareholders of Corona Remedies Ltd.?

Significant shareholdings in Corona Remedies Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Corona Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Corona Remedies Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Corona Remedies Ltd.?

Corona Remedies Ltd. last declared a FINAL dividend of ₹ 10 per share for the financial period ending 2026. The record date was set as 2026-06-19, and the payment was/is scheduled around 2026-06-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy